Studies related to Subjective Well-Being and Kava

Kava-kava Extract WS 1490 Versus Placebo In Anxiety Disorders--a Randomized Placebo-controlled 25-week Outpatient Trial

Effect Increase
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 101
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Average
Notes for this study:
101 patients suffering from non-psychotic anxiety using Kava (WS 1490 extract) over 25 weeks noted statistically significant benefits starting after week 8.

Full details on all 4 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.